9 studies found for:    MK-4305
Show Display Options
Rank Status Study
1 Completed A Study to Evaluate Next Day Effects of MK-4305 on Driving Performance (MK-4305-035 AM1)
Condition: Insomnia
Interventions: Drug: MK-4305 40 mg;   Drug: MK-4305 20 mg;   Drug: Zopiclone;   Drug: Grossly Matching Placebo for Zopiclone;   Drug: Matching Placebo for MK-4305
2 Completed Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
Condition: Primary Insomnia
Interventions: Drug: MK4305;   Drug: Comparator: Placebo
3 Completed A Long Term Safety Study of MK4305 in Patients With Primary Insomnia (4305-009 AM3)
Condition: Insomnia
Interventions: Drug: MK4305;   Drug: Comparator: Placebo to MK4305
4 Completed Pharmacokinetics of MK4305 in Participants With Impaired Renal Function (MK-4305-023)(COMPLETED)
Condition: Insomnia
Intervention: Drug: MK-4305
5 Completed Effects of MK-4305 in Participants With Obstructive Sleep Apnea (MK-4305-036 AM1)
Conditions: Sleep Apnea;   Obstructive
Interventions: Drug: MK-4305;   Drug: Matching Placebo
6 Completed Pharmacokinetics of MK4305 in Patients With Hepatic Insufficiency
Conditions: Insomnia;   Hepatic Insufficiency
Intervention: Drug: MK4305
7 Completed Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
Condition: Primary Insomnia
Interventions: Drug: Suvorexant (MK4305);   Device: Comparator: Placebo
8 Completed Effects of MK-4305 (Suvorexant) in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032 AM3)
Condition: Insomnia
Interventions: Drug: suvorexant;   Drug: Placebo
9 Completed Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)
Condition: Primary Insomnia
Interventions: Drug: Suvorexant;   Drug: Dose-matched Placebo to Suvorexant

Indicates status has not been verified in more than two years